MedTrace Logo

Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae

NCT04278482 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2023-01-17

No results posted yet for this study

Summary

Vegetarian diets are increasing worldwide. To prevent nutritional deficiencies, supplementation with nutrients that are only present in animal food can be needed. In relation to fatty acids, vegetarian diets involve low intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) and low blood levels of the long-chain n-3 derivatives, whose main dietary sources are fish and shellfish, particularly the levels of docosahexaenoic acid (DHA), which has important health benefits, are low.

In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not obtained from fish is needed, thus the study will test the bioavailability and metabolic effects of a DHA supplement form algae.

The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian and non-vegetarian healthy adults.

Conditions

  • Vegetarian Diet

Interventions

DIETARY_SUPPLEMENT

Dietary supplement, DHA or Placebo

Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo

Sponsors & Collaborators

  • Comunidad de Madrid

    collaborator OTHER

  • National Research Council, Spain

    lead OTHER_GOV

Principal Investigators

  • M.Pilar Vaquero, Dr · CSIC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-10
Primary Completion
2021-07-05
Completion
2021-07-05

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04278482 on ClinicalTrials.gov